David Alexander Potter, MD
University of Minnesota
Topic Presenter
Financial Disclosure
Quantum Leap Healthcare Collaborative, Olema Oncology, TransCode Therapeutics, GSK, Iambic Therapeutics, Pfizer, Abbvie, Gilead, ImmunoMet Therapeutics, Daiichi Sankyo, Jazz, Alx Oncology, MJH Lifesciences, Dava Oncology, Momentum, Aptitude, CEA Group, Curio, Dedham Group, Decera Clinical Insights, Keyquest Health, General Dynamics, Department of War, NIH.
Other
Research Support DOD CDMRP Breast Cancer Program, Minnesota Partnership for Biotechnology and Medical Genomics, National Cancer Institute of Mexico, Randy Shaver Foundation, Quantum Leap Healthcare Collaborative.
Other
University of Minnesota
Employee
Researcher